Interview: Bart Roep – Director, Diabetes Expert Center, Leiden…
Winner of the Dutch Prix Corona Gallina in 2011, Prof. Dr. Bart Roep discusses his groundbreaking research into type 1 diabetes; his wishes to deal with the cause rather than…
Address: Albinusdreef 2, 2333 ZA Leiden, the Netherlands
,Netherlands
Tel: +31 71 5269111
Web: https://www.lumc.nl/home/
One of the eight medical centres in the Netherlands, the Leiden University Medical Center (LUMC) has five core tasks:
patient care
scientific research
education
study programmes
continuing education.
The LUMC employs 7000 people.
Patient care is largely focused on highly specialised care, the sort of care that cannot be provided anywhere else. The LUMC also offers a broad package of top-level clinical care, including organ transplants, cardiovascular interventions and all types of bone marrow transplants.
The research conducted in the LUMC is both fundamental and patient- and care-oriented. A considerable portion of the research centres on the translation from fundamental research to its use in patient care (from bench to bedside and vice versa). A good example is the recently opened C.J. Gorter Center, one of the world’s prominent centres in the area of MRI research.
The C.J. Gorter Center has installed the first 7Tesla MRI scanner in the Netherlands for use with humans. The research in the LUMC will be aimed at early diagnosis of Alzheimer’s, a better understanding of migraine, the energy economy in healthy people and patients with diabetes, and the process of ageing. Important research themes in the LUMC are: ageing, neurosciences, vascular medicine, infectious diseases and immunology, cancer immunotherapy, regenerative medicine, oncogenetics, genetic epidemiology and bio-informatics.
The LUMC offers degree courses in Medicine and Biomedical Sciences. The training of medical specialists is also a core task of the LUMC. Medical specialists are trained in 27 specialities in collaborative clusters of general hospitals in the vicinity.
The Boerhaave Committee is another part of the LUMC. Its focus is the provision of high-quality training at post-academic and post-graduate as well post-vocational levels.
patient care
scientific research
education
study programmes
continuing education
Winner of the Dutch Prix Corona Gallina in 2011, Prof. Dr. Bart Roep discusses his groundbreaking research into type 1 diabetes; his wishes to deal with the cause rather than…
Your role as Chair of the Executive Board is a mix between CEO and CMO. On a daily basis, which do you see yourself as more – the Chief Executive…
A very strong phrase that we recently came across describes a “war going on in the generics industry” as a result of the preference policy, which people have claimed has…
Bioceros was founded as a service company built on the immunology expertise of its founders. Additional cell line expertise was added when you joined in 2007. What made this combination…
We do not often meet companies that have been successful at retaining their manufacturing facilities in the Netherlands. How and why did former Katwijk Farma -and now Apotex- succeed to…
Clearly the end of 2010 was an exciting time for you. As you entered the transition period as the new CEO of OctoPlus, you also participated in the equity raising.…
As the founder of the Institute of Young Entrepreneurs at the Delft University of Technology and an enthusiastic promoter of innovation and new technologies, what do you believe distinguishes a…
Pfizer is well placed for the next generation of growth. Coming off great M&A’s and now restructuring internally, (from the country structure to the business units). After closing 2010, the…
Certain cities have specific institutions, foundations, or in this case, science parks that serve as a microcosm for that city. How does Utrecht Science Park embody the identity and strengths…
While doing our research we couldn’t help but notice that you are quite passionate about issues related to healthcare and an avid proponent of healthcare reform. In this vein, what…
IMS Health sets itself apart because of its global reach, while mastering local expertise. Clearly, every market is one of a kind. What is so particular about the Dutch market?…
As the chairman of a consortium that has been working towards both medical and technological progress in the region, how have you seen this progress taking place in the Netherlands…
Deloitte is renowned for its strong network of international expertise. Yet every market has its own particularities… Having spent 16 years with the company, in your opinion, what is it…
Your role as Chair of the Executive Board is a mix between CEO and CMO. On a daily basis, which do you see yourself as more – the Chief Executive…
See our Cookie Privacy Policy Here
